DNLI — DENALI THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 305 SEC-registered investment managers reported holding DNLI (DENALI THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $4.74B across 170.35M shares. That is +6.7% by share count (+10.04M shares) versus the previous quarter, while reported value moved +42.2%. Ownership is concentrated: the five largest holders account for 36.4% of reported value and the top ten for 51.8%.
Compared with the prior quarter, 54 opened new positions, 123 added to existing stakes, 70 trimmed, 33 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of DENALI THERAPEUTICS INC (DNLI) include T. Rowe Price Investment Management, Inc., BlackRock Inc, Baillie Gifford & Co, ranked by reported 13F value among the 507 institutional holders on this page.
DNLI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 218 | 95.60M | $1.98B | -1.0% |
| Q2 2026 | 305 | 170.35M | $4.74B | +5.0% |
| Q1 2026 | 282 | 160.80M | $3.03B | -0.5% |
| Q4 2025 | 256 | 166.30M | $2.68B | +5.9% |
| Q3 2025 | 239 | 155.08M | $2.19B | -3.7% |
| Q2 2025 | 229 | 159.29M | $2.14B | -4.9% |
| Q1 2025 | 222 | 161.44M | $2.14B | +8.0% |
| Q4 2024 | 221 | 149.19M | $2.98B | -1.4% |
Over the 8 quarters shown, institutional share counts decreased 36% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+8.0%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.33M | $296.17M | 0.01% | Add | |
| 11.12M | $229.85M | 0.22% | Reduce | |
| 7.01M | $144.96M | 0.41% | Hold | |
| 6.76M | $139.70M | 0.01% | Add | |
| 6.75M | $139.55M | 0.00% | Add | |
| 6.68M | $138.12M | 0.00% | Add | |
| 4.53M | $93.70M | 0.00% | Hold | |
| 4.04M | $83.50M | 0.00% | Add | |
| 2.92M | $60.33M | 0.01% | Add | |
| 2.56M | $52.98M | 0.01% | Hold | |
| 2.50M | $51.75M | 0.02% | Reduce | |
| 2.46M | $50.86M | 0.02% | Add | |
| 1.59M | $32.96M | 0.04% | Reduce | |
| 1.54M | $31.89M | 0.03% | Add | |
| 1.52M | $31.43M | 0.04% | Add | |
| 1.40M | $28.87M | 0.69% | Hold | |
| 1.37M | $28.35M | 0.00% | Add | |
| 1.27M | $26.27M | 0.01% | Reduce | |
| 1.07M | $22.19M | 0.10% | Reduce | |
| 1.06M | $21.87M | 0.04% | Reduce | |
| 1.06M | $21.87M | 0.01% | Add | |
| 854.68K | $17.67M | 0.00% | Add | |
| 803.42K | $16.61M | 0.03% | Add | |
| 783.16K | $16.19M | 0.00% | Reduce | |
| 625.00K | $12.92M | 1.77% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.06M | $215.59M | 0.00% | Add | |
| 12.72M | $209.93M | 0.01% | Add | |
| 12.31M | $203.25M | 0.17% | Add | |
| 7.25M | $119.77M | 0.08% | Add | |
| 7.01M | $115.78M | 0.37% | Add | |
| 7.01M | $115.78M | 0.44% | Add | |
| 6.26M | $103.41M | 0.00% | Add | |
| 6.10M | $100.66M | 0.01% | Reduce | |
| 5.12M | $84.52M | 0.01% | Add | |
| 4.98M | $82.28M | 0.02% | Reduce | |
| 3.92M | $64.65M | 0.01% | Reduce | |
| 3.84M | $63.33M | 0.03% | Add | |
| 3.73M | $61.61M | 0.38% | Hold | |
| 3.73M | $61.57M | 0.01% | Reduce | |
| 3.73M | $61.57M | 0.01% | Reduce | |
| 3.56M | $58.74M | 0.02% | Add | |
| 3.46M | $57.10M | 0.00% | Hold | |
| 3.15M | $52.05M | 0.11% | Add | |
| 2.81M | $46.41M | 87.02% | Reduce | |
| 2.59M | $42.75M | 0.01% | Add | |
| 2.40M | $39.70M | 0.02% | Add | |
| 2.37M | $39.20M | 0.01% | Add | |
| 2.03M | $33.56M | 0.05% | Add | |
| 1.84M | $30.38M | 1.89% | Add | |
| 1.74M | $28.71M | 5.81% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.29M | $178.45M | 0.01% | Add | |
| 11.99M | $174.14M | 0.00% | Add | |
| 11.59M | $168.31M | 0.12% | Reduce | |
| 6.34M | $92.06M | 0.01% | Reduce | |
| 5.64M | $81.87M | 0.05% | Add | |
| 5.47M | $79.35M | 0.02% | Reduce | |
| 5.46M | $79.34M | 0.00% | Add | |
| 5.36M | $77.77M | 0.29% | Hold | |
| 5.36M | $77.77M | 0.27% | Hold | |
| 4.76M | $69.13M | 0.01% | Hold | |
| 4.76M | $69.13M | 0.01% | Hold | |
| 4.57M | $66.33M | 0.01% | Reduce | |
| 4.12M | $59.82M | 0.01% | Add | |
| 3.73M | $54.18M | 0.40% | Hold | |
| 3.52M | $51.12M | 0.02% | Add | |
| 3.47M | $50.34M | 0.00% | Add | |
| 3.41M | $49.52M | 85.25% | Reduce | |
| 3.14M | $45.53M | 0.11% | Add | |
| 2.52M | $36.58M | 0.14% | Add | |
| 2.36M | $34.23M | 0.01% | Reduce | |
| 2.16M | $31.42M | 0.01% | Add | |
| 2.01M | $29.22M | 0.02% | Add | |
| 1.73M | $25.19M | 6.50% | Add | |
| 1.69M | $24.53M | 0.00% | Add | |
| 1.63M | $23.69M | 0.01% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.05M | $168.63M | 0.01% | Reduce | |
| 11.96M | $167.25M | 0.12% | Reduce | |
| 11.81M | $165.23M | 0.00% | Hold | |
| 7.54M | $105.46M | 0.01% | Add | |
| 6.58M | $92.09M | 0.01% | Add | |
| 6.26M | $87.61M | 0.02% | Reduce | |
| 5.66M | $79.25M | 0.02% | Reduce | |
| 5.66M | $79.25M | 0.01% | Reduce | |
| 5.36M | $74.93M | 0.40% | Hold | |
| 5.36M | $74.93M | 0.29% | Hold | |
| 4.75M | $66.46M | 0.01% | Hold | |
| 4.75M | $66.46M | 0.01% | Hold | |
| 4.52M | $63.21M | 0.00% | Add | |
| 3.95M | $55.22M | 0.01% | Add | |
| 3.86M | $54.01M | 86.33% | Reduce | |
| 3.73M | $52.21M | 0.51% | Hold | |
| 3.25M | $45.42M | 0.03% | New | |
| 3.17M | $44.39M | 0.00% | Add | |
| 3.14M | $43.89M | 0.01% | Reduce | |
| 2.41M | $33.76M | 0.01% | Add | |
| 2.21M | $30.97M | 0.15% | New | |
| 1.87M | $26.10M | 0.01% | Add | |
| 1.52M | $21.21M | 0.01% | Add | |
| 1.41M | $19.66M | 0.03% | Reduce | |
| 1.31M | $18.36M | 0.00% | Add |
New Positions (Q2 2026)
- Banque Cantonale Vaudoise 17.93K sh · $461.00M
- GEODE CAPITAL MANAGEMENT, LLC 3.97M sh · $102.21M
- Sixth Street Partners Management Company, L.P. 1.24M sh · $32.02M
- ExodusPoint Capital Management, LP 336.57K sh · $8.66M
- E. Ohman J:or Asset Management AB 160.00K sh · $4.12M
- Odyssean, LLC 125.06K sh · $3.22M
- PFM Health Sciences, LP 100.97K sh · $2.60M
- Integral Health Asset Management, LLC 100.00K sh · $2.57M
- Phocas Financial Corp. 71.20K sh · $1.83M
- Jupiter Topco LLC 60.03K sh · $1.54M
- Savvy Advisors, Inc. 45.19K sh · $1.16M
- TUDOR INVESTMENT CORP ET AL 40.97K sh · $1.05M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 6.27M sh · $120.42M
- Vestal Point Capital, LP sold 1.77M sh · $34.05M
- STEMPOINT CAPITAL LP sold 426.56K sh · $8.19M
- BRAIDWELL LP sold 296.32K sh · $5.69M
- SCHRODER INVESTMENT MANAGEMENT GROUP sold 285.82K sh · $5.17M
- Palo Alto Investors LP sold 234.58K sh · $4.50M
- SECTOR GAMMA AS sold 162.71K sh · $3.12M
- Greenland Capital Management LP sold 99.00K sh · $1.90M
- Y-Intercept (Hong Kong) Ltd sold 78.01K sh · $1.50M
- Caption Management, LLC sold 74.60K sh · $1.43M
- Polen Capital Management sold 65.30K sh · $1.25M
- Janus Henderson Group sold 60.03K sh · $1.15M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 14.33M | 14.03M | 13.03M | 12.72M | 12.29M | 12.05M | 13.83M | 13.92M | 13.79M | — | — | — | — | — | — | — | — | — | — | — |
| Baillie Gifford & Co | 11.12M | 11.96M | 12.07M | 12.31M | 11.59M | 11.96M | 12.09M | 12.31M | 13.35M | 13.76M | 14.04M | 14.26M | 14.68M | 14.84M | 15.35M | 15.12M | 14.72M | 14.87M | 14.98M | 15.06M |
| Temasek Holdings (Private) Ltd | 7.01M | 7.01M | 7.01M | 7.01M | 5.36M | 5.36M | 5.36M | 5.36M | 5.36M | 5.71M | 5.71M | 6.90M | 6.90M | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.76M | 6.48M | 6.12M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.75M | 6.28M | 6.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 6.68M | — | 6.27M | 6.26M | 5.46M | 4.52M | 4.46M | 4.54M | 4.25M | 4.43M | 6.32M | 5.49M | 4.28M | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 4.53M | 4.54M | 4.58M | 6.10M | 6.34M | 7.54M | 7.41M | 8.02M | 7.83M | 234.87K | 1.23M | 641.65K | 1.06M | 1.08M | 1.09M | 2.21M | 2.45M | 2.87M | 2.94M | 2.95M |
| Geode Capital Management | 4.04M | 3.97M | 3.73M | 3.46M | 3.47M | 3.17M | 3.04M | 2.94M | 2.96M | 2.98M | 2.76M | 2.66M | 2.53M | 2.32M | 2.15M | 2.05M | 1.78M | 1.71M | 1.63M | 1.63M |
| DIMENSIONAL FUND ADVISORS LP | 2.92M | 2.86M | 2.69M | 2.37M | 2.36M | 2.41M | 2.10M | 1.86M | 1.56M | 1.42M | 1.33M | 1.12M | 973.23K | — | — | — | — | — | — | — |
| Capital Research Global Investors | 2.56M | 2.57M | 2.51M | 3.73M | 4.76M | 4.75M | 4.77M | 5.48M | 7.91M | 7.13M | 6.05M | 2.91M | 2.88M | — | — | — | — | — | — | — |
| UBS Group AG | 2.50M | 3.12M | 2.57M | 2.40M | 2.01M | 950.76K | 788.43K | 852.86K | 141.40K | 136.22K | 343.88K | 290.99K | 109.70K | 131.94K | 127.35K | 120.18K | 42.45K | 6.38K | 39.11K | 92.35K |
| Fisher Asset Management, LLC | 2.46M | 2.41M | 2.44M | 2.59M | 1.63M | 1.52M | 1.36M | 792.50K | 547.33K | 478.11K | 469.17K | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 1.59M | 2.79M | 2.56M | 1.33M | 499.16K | 415.11K | 343.96K | 19.36K | 16.55K | 13.80K | 13.80K | 439.22K | 589.50K | — | — | — | — | — | — | — |
| BNP Paribas Asset Management Holding S.A. | 1.54M | 1.36M | 296.50K | 298.79K | 1.27K | 1.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 1.52M | 1.35M | 1.85M | 2.03M | 1.11M | 902.75K | 759.82K | 402.28K | 363.68K | 573.03K | 516.02K | 324.83K | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 1.40M | 1.40M | 1.40M | 1.40M | 821.51K | 821.51K | 821.51K | 834.03K | 834.03K | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1.37M | 961.05K | 1.10M | 1.22M | 1.69M | 1.31M | 1.25M | 1.23M | 1.74M | 1.22M | 928.13K | 977.49K | 981.57K | 1.08M | 569.12K | 432.49K | 681.33K | 423.01K | 705.65K | 287.26K |
| Principal Global Investors | 1.27M | 1.42M | 1.48M | 1.52M | 1.27M | 1.07M | 1.08M | 1.13M | 1.24M | 1.09M | 1.12M | 1.07M | 680.08K | 686.49K | 488.96K | 526.46K | 545.87K | 267.73K | 269.00K | 330.27K |
| Candriam S.C.A. | 1.07M | 1.19M | 1.10M | 1.17M | 833.58K | 844.25K | 858.16K | 832.98K | 942.16K | 726.50K | 447.88K | 357.88K | 357.88K | — | — | — | — | — | — | — |
| Artisan Partners Limited Partnership | 1.06M | 1.22M | 1.10M | — | — | — | 612.44K | 1.05M | 1.09M | 1.14M | 365.83K | 383.94K | 406.62K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold DNLI?
As of 2026-Q2, 305 institutional funds reported holding DNLI (DENALI THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $4.74B.
How many shares of DNLI do institutions own?
13F filers reported 170.35M shares of DNLI, worth $4.74B in aggregate at the end of 2026-Q2.
Is institutional ownership of DNLI rising or falling?
Share counts moved +6.7% versus the prior quarter — accumulation.
Who are the top institutional holders of DNLI?
The largest 13F holders are T. Rowe Price Investment Management, Inc., BlackRock Inc, Baillie Gifford & Co, Vanguard Group, Temasek Holdings; the top 25 are ranked at the top of this page.
Who are the major shareholders of DENALI THERAPEUTICS INC?
The major shareholders of DENALI THERAPEUTICS INC (DNLI) by reported 13F value are T. Rowe Price Investment Management, Inc., BlackRock Inc, Baillie Gifford & Co, Vanguard Group, Temasek Holdings, among 507 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.